Main reason to me, is NHL's peer, Akili, raised US$140m and sold a right in two regions (Japan & Taiwan's market) for US$20m upfront & US$105m milestone payments & development costs.
Akili main product is ADHD, exactly same to TAli Train, but targeting different ages.
I don't need to repeat But it's just way undervalued compared with peer, imo. DYOR.
NHL Charts, page-483
-
- There are more pages in this discussion • 6,432 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TD1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.295M | |||
| Open | High | Low | Value | Volume |
| 0.1¢ | 0.1¢ | 0.1¢ | $272 | 271.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 41230235 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 51151172 | 21 |
View Market Depth
| Last trade - 10.09am 25/07/2024 (20 minute delay) ? |
| TD1 (ASX) Chart |